Literature DB >> 26623083

The use of statins in patients with heart failure: more questions than answers.

Peter C Westman1, Michael J Lipinski1.   

Abstract

The use of statins to treat patients with heart failure (HF) is controversial due to conflicting results from large, prospective, randomized, placebo-controlled trials and other smaller studies. A recent comprehensive, well-conducted meta-analysis from Preiss and colleagues sought to determine whether statin therapy had an effect on major HF outcomes such as hospitalization and death. Although the study demonstrated a significant effect of statin therapy on HF hospitalizations, several limitations involving the participant data and nature of statin used in the analyzed trials raise questions about the inferences that can be drawn from the study results.

Entities:  

Keywords:  Hydroxymethylglutaryl-CoA reductase inhibitors; heart failure (HF); meta-analysis

Year:  2015        PMID: 26623083      PMCID: PMC4635278          DOI: 10.3978/j.issn.2072-1439.2015.10.47

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  18 in total

1.  Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.

Authors:  Wilbert S Aronow; Chul Ahn
Journal:  Am J Cardiol       Date:  2002-07-15       Impact factor: 2.778

2.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

3.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

Review 4.  Effects of lipophilic statins for heart failure: a meta-analysis of 13 randomised controlled trials.

Authors:  Gang Liu; Xin-Xin Zheng; Yan-Lu Xu; Jie Lu; Ru-Tai Hui; Xiao-Hong Huang
Journal:  Heart Lung Circ       Date:  2014-05-28       Impact factor: 2.975

Review 5.  Heart failure.

Authors:  John J V McMurray; Marc A Pfeffer
Journal:  Lancet       Date:  2005 May 28-Jun 3       Impact factor: 79.321

6.  Rosuvastatin in older patients with systolic heart failure.

Authors:  John Kjekshus; Eduard Apetrei; Vivencio Barrios; Michael Böhm; John G F Cleland; Jan H Cornel; Peter Dunselman; Cândida Fonseca; Assen Goudev; Peer Grande; Lars Gullestad; Ake Hjalmarson; Jaromir Hradec; András Jánosi; Gabriel Kamenský; Michel Komajda; Jerzy Korewicki; Timo Kuusi; François Mach; Vyacheslav Mareev; John J V McMurray; Naresh Ranjith; Maria Schaufelberger; Johan Vanhaecke; Dirk J van Veldhuisen; Finn Waagstein; Hans Wedel; John Wikstrand
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

Review 7.  Long-term clinical outcomes of statin use for chronic heart failure: a meta-analysis of 15 prospective studies.

Authors:  Jian-Qiang Wang; Guo-Rong Wu; Zheng Wang; Xiao-Ping Dai; Xiang-Rong Li
Journal:  Heart Lung Circ       Date:  2013-08-17       Impact factor: 2.975

8.  Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).

Authors:  Jennifer K Rogers; Pardeep S Jhund; Ana-Cristina Perez; Michael Böhm; John G Cleland; Lars Gullestad; John Kjekshus; Dirk J van Veldhuisen; John Wikstrand; Hans Wedel; John J V McMurray; Stuart J Pocock
Journal:  JACC Heart Fail       Date:  2014-04-30       Impact factor: 12.035

9.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

Review 10.  The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.

Authors:  David Preiss; Ross T Campbell; Heather M Murray; Ian Ford; Chris J Packard; Naveed Sattar; Kazem Rahimi; Helen M Colhoun; David D Waters; John C LaRosa; Pierre Amarenco; Terje R Pedersen; Matti J Tikkanen; Michael J Koren; Neil R Poulter; Peter S Sever; Paul M Ridker; Jean G MacFadyen; Scott D Solomon; Barry R Davis; Lara M Simpson; Haruo Nakamura; Kyoichi Mizuno; Rosa M Marfisi; Roberto Marchioli; Gianni Tognoni; Vasilios G Athyros; Kausik K Ray; Antonio M Gotto; Michael B Clearfield; John R Downs; John J McMurray
Journal:  Eur Heart J       Date:  2015-03-23       Impact factor: 29.983

View more
  3 in total

1.  Perceived symptoms as the primary indicators for 30-day heart failure readmission.

Authors:  Kelley M Anderson; Dottie Murphy; Hunter Groninger; Paul Kolm; Haijun Wang; Vera Barton-Maxwel
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752

2.  No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials.

Authors:  Muaamar Al-Gobari; Hai-Ha Le; Mor Fall; François Gueyffier; Bernard Burnand
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

Review 3.  Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications.

Authors:  Armita Mahdavi Gorabi; Nasim Kiaie; Saeideh Hajighasemi; Maciej Banach; Peter E Penson; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  J Clin Med       Date:  2019-11-22       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.